We previously reported that the atrial natriuretic polypeptide (ANP) caused a relaxant effect with the tissue cyclic GMP (c-GMP) levels on a guinea pig tracheal smooth muscle .
We previously reported that the atrial natriuretic polypeptide (ANP) caused a relaxant effect with the tissue cyclic GMP (c-GMP) levels on a guinea pig tracheal smooth muscle .
We studied plasma immunoreactive ANP and c-GMP concentrations in various situations in patients with respiratory diseases which were divided into 3 groups , patients with bronchial asthma (BA, n=16), patients with chronic pulmonary emphysema (CPE , n=10) and patients with pulmonary insufficiency induced by pulmonary tuberculosis (Tbc , n=44). One hundred and thirteen healthy subjects were also studied as a control group . This is the first report that these clinical markers have been measured at same time in the field of respiratory diseases .
In conclusion, 1) Plasma ANP was significantly higher in patients with BA (attack) (P< 0.05) and Tbc (P<0.01) than in control. 2) Plasma c-GMP was significantly higher in patients with Tbc (P<0.01) than with BA (remission) . 3) There was a significant correlation between plasma c-GMP and log ANP in patients with chronic respiratory disease (r=0 .714, P<0.05, n=72). 4) Plasma ANP was significantly higher at attack than at remission (P<0 .05).
These results indicate that effects of ANP in patients with respiratory disease may be , atl east in part, mediated by c-GMP being in the place of cyclic AMP , and ANP induced by pulmonary hypertention may cause a relaxant effect on tracheal and vascular smooth muscle . Therefore, exogenous ANP may also be useful on the therapy of patients with bronchial asthma. such as intractable asthma 
